Thursday December 3, 2020 20:34

Heathcare Press Release : 10 Nov 2020

Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Heathcare—10 Nov 20

- Phase II a trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease" - Out-licencing deal includes 10% equity in Vera Therapeutics and up to EUR 605 million in development and commercial milestones,

OrbusNeich(R) Medical and P+F Products & Features(R) announce new Heathcare—10 Nov 20

OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative minimally invasive heart valve products in the Asia Pacific region, including China, Japan, Taiwan, South